heroin was promoted as a cough medication and a treatment for lung diseases. But problems flowing from addiction led many to perceive the drug element of medications to be morally destructive. In the United States, the Supreme Court decisions of Webb et al. v U.S. 249 U.S. 96 (1919) and U.S. v Behrman 258 U.S. 280 (1922) drove the use of narcotics underground and consolidated their criminal status. In the terms adopted by Schur (1965), drug dealing is now victimless because neither the buyer nor the seller is likely to report it. The consumption of some drugs can damage the health of users causing indirect societal cost due to increased hospitalizations and, in some cases, cause death through overdose because substitution or poor quality, although this potential for harm may be operationally indistinct from the potentials for harm associated with other noncriminal behaviors, such as driving a car while tired or over-consumption of healthy foods. Some argue that if drugs were available legally, they would be less harmful (see the drug policy of the Netherlands). When drugs are illegal, the price is higher, and maintaining the habit takes the money that would otherwise be spent on food, shelter, and clothing. The resultant neglect is a contributory factor to the addict's physical deterioration. In Australia, Walker (1991) finds a strong link between substance abuse and crime. In general, making drugs illegal results in an exponential increase in their price so that addicts must indulge in theft, robbery, and burglary to support their habits. Those people who experience those crimes are indirect victims of the drug sale. The need to fund addiction also drives some into distribution where they are more prone to violent attack and murder. These findings are matched elsewhere. Meier and Geis (1997) confirm that drug dealing is an area where victims are third parties who experience harm only indirectly through, say, losses from drug-related crime, and the costs of enforcing drug laws and of treating addiction, and the public health costs for treating illness and disease consequent on the addiction, e.g., HIV infection through using the same needles. In Australia, for example, the National Campaign against Drug Abuse (see Collins & Lapsley 1991) gives a figure of just over $1.2 billion for total costs of the abuse of illicit drugs in Australia in 1988, including treatment of drug-related illness, accidents resulting from drug use/misuse, loss of productivity due